Title of Invention

PREPARATION OF D-PANTOTHENIC ACID AND/OR SALTS THEREOF AS ADDITIVE TO ANIMAL FEEDSTUFFS

Abstract The present invention relates to a process for preparing D-pantothenic acid and/or salts thereof which comprises a) using at least one microorganism which produces D-pantothenic acid and in which the biosynthesis of pan- tothenic acid (pan) and/or isoleucine/valine (ilv) is deregulated and which forms at least 2 gil of salts of D-pantothenic acid by fermentation in a culture medium,. 0 -20 gil of free β-alanine and/or β-alanine salt being supplied to the culture medium, b) passing the D-pantothenate-comprising fermentation solution through one or more ion-selective membrane (s) by applying an electric field, low-molecular-weight ions being removed from the D-pantothenate-containing solution, c) adding a calcium base and/or magnesium base to set the free D-pantothenic acid comprised in the solution to a pH of 3-10, a solution being obtained which contains calcium and/or magnesium pantothenate and d) subjecting the calcium pantothenate- and/or magnesium pantothenate-comprising solution to ' drying and/or formulation.
Full Text We claim:
1. A process for preparing D-pantothenic acid and/or
salts thereof which comprises
a) using at least one organism which produces D-pantothenic acid and in which the biosynthesis of pantothenic acid (pan) and/or isoleucine/valine (ilv) is deregulated and which forms at least 2 g/1 of salts of D-pantothenic acid by fermentation in a culture medium, 0 - 20 g/1 of free p-alanine and/or P-alanine salt being supplied to the culture medium,
b) passing the D-pantothenate-containing fermentation solution through one or more ion-selective membrane(s) by applying an electric field, low-molecular-weight ions being removed from the D-pantothenate-containing solution,

c) adding a calcium base and/or magnesium base to set the free D-pantothenic acid contained in the solution to a pH of 3-10, a solution being obtained which contains calcium and/or magnesium pantothenate and
d) subjecting the calcium pantothenate-and/or magnesium pantothenate-containing solution to drying and/or formulation.
2. A process as claimed in claim 1, wherein no free
p-alanine and/or p-alanine salt is fed to the
culture medium.
3. A process as claimed in either one of claims 1 and
2, wherein the D-pantothenic-acid-preducing

organism used is a bacterium, a yeast or a fungus.
4. A process as claimed in any one of claims 1 to 3, wherein the microorganism used is a bacterium from the Bacillaceae family.
5. A process as claimed in any one of claims 1 to 4, wherein a bacterium of the genus Bacillus and preferably the species B. subtils, B. licheniformis or B. amyloliquefaciens, is used.
6. A process as claimed in any one of claims 1 to 5, wherein, in step a) a content of D-pantothenic acid and/or salts thereof of at least 10 g/1 of culture medium, preferably at least 20 g/1, particularly preferably at least 40 g/1 and very highly preferably at least 60 g/1 of culture medium is formed.
7. A process as claimed in any one of claims 1 to 6, wherein, in step c), the pH of the solution is set to 5-10.

8. A process as claimed in any one of claims 1 to 7, wherein, in step c), the pH of the solution is set to 5-9, preferably 6-9, and particularly preferably 6-8.
9. A process as claimed in any one of claims 1 to 8, wherein, in step b), monopolar and/or bipolar ion-exchange membranes are used.
10. A process as claimed in any one of claims 1 to 9, wherein, in step b) , monopolar ion-exchange membranes are used.
11. A process as claimed in any one of claims 1 to 10, wherein, in step b), monoselective ion-exchange membranes are used.

12. A process as claimed in any one of claims 1 to 11, wherein the pH of the D-pantothenic-acid-containing fermentation solution, before the treatment in step b) , is set to the isoelectric pH of D-pantothenic acid.
13. A process as claimed in any one of claims 1 to 12, wherein, in step b) , current densities of 1-100 mA/cm2, preferably 10-80 mA/cm2 and particularly preferably 20-40 mA/cm2, are set for monopolar ion-exchange membranes -
14. A process as claimed in any one of claims 1 to 13, wherein, in step b), current densities of 1-150 mA/cm2, preferably 30-100 mA/cm2 and particularly preferably 70-90 mA/cm2, are set for bipolar ion-exchange membranes.

15. A process as claimed in any one of claims 1 to 14, wherein, in step b) , the content of monovalent cations, preferably ammonium, potassium and/or sodium ions, is reduced to a concentration of 16. A process as claimed in any one of claims 1 to 15, wherein, for neutralization, calcium hydroxide, calcium carbonate, calcium oxide, magnesium hydroxide and/or basic magnesium carbonate is added in the form of a solid and/or as aqueous suspension to the solution in step c).
17. A process as claimed in any one of claims 1 to 16, wherein an aqueous suspension comprising 2-55% by weight, preferably 10-50% by weight, and particularly preferably 20-40% by weight, of calcium hydroxide is added to the solution in step c) .

18. A process as claimed in any one of claims 1 to 17, wherein an aqueous suspension comprising 2-65% by weight, preferably 10-50% by weight, and particularly preferably 20-40% by weight, of calcium carbonate is added to the solution in step c) .
19. A process as claimed in any one of claims 1 to 18, wherein an aqueous suspension comprising. 20-60% by weight, preferably 10-50% by weight, and particularly preferably 20-40% by weight, of magnesium hydroxide is added to the solution in step c).
20. A process as claimed in any one of claims 1 to 19, wherein an aqueous suspension comprising 2-25% by weight, preferably 10-20% by weight, of basic magnesium carbonate is added to the solution in step c).
21. A process as claimed in any one of claims 1 to 20, wherein, in step c) or d), a suspension is obtained or charged which contains calcium pantothenate and/or magnesium pantothenate.
22. A composition for the use as animal feed additive and/or animal feed supplement, wherein it can be prepared by
a) using at least one organism which produces D-pantothenic acid and in which the biosynthesis of pantothenic acid (pan) and/or isoleucine/valine (ilv) is deregulated and which forms at least 2 g/1 of salts of D-pantothenic acid by fermentation in a culture medium, 0-20 g/1, preferably 0 g/1, of free p-alanine and/or β-alanine salt being supplied to the culture medium.

b) passing the D-pantothenate-containing fermentation solution through one or more ion-selective membrane(s) by applying an electric field, low-molecular-weight ions being removed from the D-pantothenate-containing solution,
c) adding a calcium base and/or magnesium base to set the free D-pantothenic acid con tainted in the solution to a pH of 3-10, a solution being obtained which contains calcium and/or magnesium pantothenate and
d) subjecting the calcium pantothenate- and/or magnesium pantothenate-containing solution to drying and/or formulation.

23. A composition as claimed in claim 22, wherein in step c) or d) , a suspension is obtained or is present which contains calcium pantothenate and/or magnesium pantothenate.
24. A composition as claimed in either of claims 22 and 23 which comprises D-pantothenic acid salts in the form of divalent cations, preferably calcium D-pantothenate and/or magnesium D-pantothenate.
25. A composition as claimed in any one of claims 22 to 24 which comprises D-pantothenic acid salts at a concentration of at least 1-100% by weight, preferably at least 20-100% by weight, and particularly preferably at least 50% by weight.
26. A composition as claimed in any one of claims 22 to 25, wherein the content of D-pantothenic acid salts in the form of monovalent cations is
27. A process for preparing D-pantothenic acid and/or salts thereof substantially as herein described and exemplified.
28. A composition substantially as herein described and exemplified.
Dated this 21 day of August 2003


Documents:

1315-chenp-2003 abstract-granded.pdf

1315-chenp-2003 claims-granded.pdf

1315-chenp-2003 description (complete)-granded.pdf

1315-chenp-2003-claims.pdf

1315-chenp-2003-correspondnece-others.pdf

1315-chenp-2003-correspondnece-po.pdf

1315-chenp-2003-description(complete).pdf

1315-chenp-2003-form 1.pdf

1315-chenp-2003-form 18.pdf

1315-chenp-2003-form 3.pdf

1315-chenp-2003-form 5.pdf

1315-chenp-2003-pct.pdf


Patent Number 225825
Indian Patent Application Number 1315/CHENP/2003
PG Journal Number 02/2009
Publication Date 09-Jan-2009
Grant Date 01-Dec-2008
Date of Filing 21-Aug-2003
Name of Patentee BASF AKTIENGESELLSCHAFT
Applicant Address D-67056 LUDWIGSHAFEN
Inventors:
# Inventor's Name Inventor's Address
1 BECK, CHRISTINE MAX-JOSEPH-STRASSE 35, 68167 MANNHEIM,
2 HARZ, HANS-PETER AM MONCHSBUSCH 22, 67373 DUDDENHOFEN,
3 LOHSCHEIDT, MARKUS STEUBENSTRASSE 88, 68199 MANNHEIM,
4 LEEMANN, MARTIN MANDELWEG 9, 64625 BENSHEIM,
5 BALDENIUS, KAI-UWE SPERLINGGASSE 1, 67063 LUDWIGSHAFEN
6 FISCHER, ANDREAS DHAUNER STRASSE 27, 67067 LUDWIGSHAFEN,
PCT International Classification Number C12P 13/02
PCT International Application Number PCT/EP02/01766
PCT International Filing date 2002-02-20
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 10108223.1 2001-02-21 Germany